Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety.
about
Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road aheadNebulised amphotericin B to eradicate Candida colonisation from the respiratory tract in critically ill patients receiving selective digestive decontamination: a cohort studyPractice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions.Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?Pulmonary epithelial lining fluid concentrations after use of systemic amphotericin B lipid formulations.Prophylactic antifungal agents used after lung transplantation.Consensus summary of aerosolized antimicrobial agents: application of guideline criteria. Insights from the Society of Infectious Diseases Pharmacists.Advances in pulmonary delivery of nanoparticles.Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antifungal, antitubercular and miscellaneous anti-infective agents.Lung transplant infection.Liposomal formulations for inhalation.Anti-Aspergillus Prophylaxis in Lung Transplantation: A Systematic Review and Meta-analysis.The effects of engineered nanoparticles on pulmonary immune homeostasis.Nebulised liposomal amphotericin B for Aspergillus lung diseases: case series and literature review.Clinical pharmacokinetics of inhaled antimicrobials.Nebulized Liposomal Amphotericin B for Treatment of Pulmonary Infection Caused by Hormographiella aspergillata: Case Report and Literature Review.Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use.Aerosolized Delivery of Antifungal Agents10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation.Invasive Microascus trigonosporus Species Complex Pulmonary Infection in a Lung Transplant Recipient.Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA).Phospholipids in pulmonary drug delivery
P2860
Q26822988-6277637B-521A-4CB3-AF34-191F1C6695A1Q33750223-045B44AC-1370-4A8E-8E17-99FAF14CD55EQ34532546-7F0FAA74-4FAD-4E9A-8B3B-42EC3E07B9A0Q36868273-BC3E8C0C-1215-41AC-A807-3921DCD37167Q37098160-00141684-0BEA-484D-87CE-7C470C454CCFQ37409856-E087095B-45AE-48D7-B714-DFB15C463476Q37697380-7BF3CD2E-CD51-4497-8444-E3D0AD0E7435Q37760514-A3F8AD17-63CF-4BDB-BF68-3F6C9268651EQ37909465-BFED3BAA-53C4-48CA-BEAD-62FADB1B7EDAQ37942644-B53B1F7F-9019-42EC-8713-7BBD69DF67E6Q38010486-EBD2E0E7-6A2B-4D11-A0D2-13329D370F9AQ38126942-3C69DDAE-8F9E-43DD-9CFF-F81D4C8A4D7DQ38156666-12909A50-CDB3-4AB8-B7F1-196BA6252BB7Q38165210-8CDF10E2-7679-4281-83F2-7CA3279FF389Q38359303-7F4147B0-7377-434E-B9F2-60492A274E6CQ38367260-8F2BF152-5FE3-40AE-BEF7-CD71A75C8DD7Q39112946-E9F35362-62C6-4710-A9C7-A2E975F3C85CQ39196802-225C9F36-AD1E-4FA2-A94C-49B0EB7F646CQ40522508-CB227316-6A84-4A40-A6EC-58DA6D1A871DQ41015559-C9C3360D-7482-4242-930B-31EA4CDF075AQ41160897-A2430AC9-3AAB-4B30-ABE0-C18A09DF2F16Q45997955-A62C2301-A8D3-4506-AF75-F517B1D96E96Q59089495-AC9B720E-EE38-4E31-ACA9-2BC04E55AE33
P2860
Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Nebulized liposomal amphoteric ...... : pharmacokinetics and safety.
@en
type
label
Nebulized liposomal amphoteric ...... : pharmacokinetics and safety.
@en
prefLabel
Nebulized liposomal amphoteric ...... : pharmacokinetics and safety.
@en
P2093
P1476
Nebulized liposomal amphoteric ...... : pharmacokinetics and safety.
@en
P2093
Albert Pahissa
Alicia de Pablo
Antonio Román
Carles Bravo
Ferran Morell
Leonor Pou
Piedad Ussetti
Rosa López
P304
P356
10.1016/J.HEALUN.2008.11.004
P577
2009-02-01T00:00:00Z